Literature DB >> 5432269

Quinacrine: mechanisms of antimalarial action.

K Van Dyke, C Lantz, C Szustkiewicz.   

Abstract

Two new interesting modes of action of quinacrine have been discovered. The first concerns a dose-related inhibition of uptake of [8-(3)H] adenosine into host cells of parasitized blood. Second, the drug inhibits the incorporation of tritiated adenosine triphosphate primarily into RNA but also into DNA of the erythrocyte-free malarial parasite Plasmodium berghei.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5432269

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  6 in total

1.  Quinacrine treatment trial for sporadic Creutzfeldt-Jakob disease.

Authors:  Michael D Geschwind; Amy L Kuo; Katherine S Wong; Aissa Haman; Gillian Devereux; Benjamin J Raudabaugh; David Y Johnson; Charles C Torres-Chae; Ron Finley; Paul Garcia; Julie N Thai; Hugo Q Cheng; John M Neuhaus; Sven A Forner; Jacque L Duncan; Katherine L Possin; Stephen J Dearmond; Stanley B Prusiner; Bruce L Miller
Journal:  Neurology       Date:  2013-10-11       Impact factor: 9.910

Review 2.  Drug target identification in protozoan parasites.

Authors:  Joachim Müller; Andrew Hemphill
Journal:  Expert Opin Drug Discov       Date:  2016-06-16       Impact factor: 6.098

3.  Beyond DNA binding - a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancers.

Authors:  Reza Ehsanian; Carter Van Waes; Stephan M Feller
Journal:  Cell Commun Signal       Date:  2011-05-15       Impact factor: 5.712

4.  Acridine and acridinones: old and new structures with antimalarial activity.

Authors:  Aymé Fernández-Calienes Valdés
Journal:  Open Med Chem J       Date:  2011-03-09

Review 5.  Overcoming cancer therapeutic bottleneck by drug repurposing.

Authors:  Zhe Zhang; Li Zhou; Na Xie; Edouard C Nice; Tao Zhang; Yongping Cui; Canhua Huang
Journal:  Signal Transduct Target Ther       Date:  2020-07-02

6.  Identification of inhibitors of ovarian cancer stem-like cells by high-throughput screening.

Authors:  Roman Mezencev; Lijuan Wang; John F McDonald
Journal:  J Ovarian Res       Date:  2012-10-18       Impact factor: 4.234

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.